@PutnamTrey

Experienced biopharmaceutical leader in product development and regulatory affairs.

 Dallas, TX
Joined December 2012
  • Tweets19
  • Following279
  • Followers63
The next big step for biosimilars. Interchangeable Biosimilars: FDA Finalizes Guidance scq.io/f6SHCBh
1
Stags Forensics Squad continue to find success this spring! TY for the updates @MelissaMreynold
1
15
Antiviral gene. lnkd.in/dmudRjk lnkd.in/dKZBFMU
2
'Is Ian cured? Maybe': the astonishing cancer treatment of Australia's chief scientist theguardian.com/science/2018…

'Is Ian cured? Maybe': the astonishing cancer treatment of Australia's chief scientist

Ian Chubb was diagnosed with metastatic kidney cancer and his prognosis was grim. But now, as far as his oncologist can tell, he is cancer-free

theguardian.com
Researchers Adapt HIV Test in Developing Rapid Diagnostic Test for Zika Virus lnkd.in/eDqdExQ
Researchers Adapt HIV Test in Developing Rapid Diagnostic Test for Zika Virus dddmag.com/news/2018/02/rese…
FDA approves first blood test to help diagnose concussions lnkd.in/eJEShtZ
Oxycontin Maker Will Stop Promoting Opioids to Doctors lnkd.in/gNZv7C7
Takeda’s Zika vaccine on the Fast Track. lnkd.in/e2RhHPz

LinkedIn

This link will take you to a page that’s not on LinkedIn

lnkd.in
Delivery of oligonucleotides has been a challenge for a long time... lnkd.in/em6nvvH

LinkedIn

This link will take you to a page that’s not on LinkedIn

lnkd.in
OGD has made significant progress since GDUFA. Here is another step to decrease the number of review cycles for ANDAs. lnkd.in/evKrbhR
1
Nice to have this settled with (hopefully) minimal disruption. lnkd.in/eea8dZ7
1
Further momentum for oligonucleotide-based therapeutics. lnkd.in/e-QHZ3m
More progress for biosimilars. lnkd.in/eSrXgJP
Big study / big data leads to better disease understanding and new targets. lnkd.in/eyNzihP
1
Historic day in drug development! lnkd.in/eVs4WfB
More momentum for CAR-T therapies! (endpts.com/fda-hands-kite-ph…)

Prepping for a rapid-fire launch, Kite Pharma gets a pass from FDA on axi-cel panel review

The FDA has evidently learned all it wants at this point from its outside oncology experts on CAR-T. Kite Pharma’s closely-watched CAR-T drug axi-cel is getting a pass on an ...

endpoints.news
A must for successful generic drug development in the US lnkd.in/eJi-juh
Researchers Find Molecular Link Between PTSD & Alzheimer's Disease dddmag.com/news/2017/08/rese…
Load more